Werewolf Therapeutics, Inc.

NasdaqGS:HOWL

Market Cap

USD 48.01 M

Share Price

USD 1.07

Avg Daily Volume

504,261

Change (1 day)

0.94%

Change (1 year)

-54.27%

Change (YTD)

-27.70%

Werewolf Therapeutics, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending December 31, 2024: -3,583.77%

Werewolf Therapeutics, Inc. EBIT Margin is -3,583.77% for the Trailing 12 Months (TTM) ending December 31, 2024, a 1,835.68% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Werewolf Therapeutics, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending December 31, 2023 was -185.14%, a -47.16% change year over year.
  • Werewolf Therapeutics, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending December 31, 2022 was -350.36%.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin